Blogging Report Sales San Diego 
Both Sides of the Table
OCTOBER 19, 2009
On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.
Xconomy
NOVEMBER 13, 2016
I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. Tim Rueth, a UC San Diego entrepreneur in residence and member of the EvoNexus selection committee, also screened the list, and offered his perspective.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
MARCH 1, 2019
biopharmaceutical industry is dealing with unprecedented threats on several fronts: public backlash against high drug prices, slowing sales, and the possibility of more government regulation. In this Report, you’ll learn: The key indicators that suggest a possible downturn is on the way. After years of boom times, the U.S.
Xconomy
JULY 7, 2016
Morristown, NJ-based Pernix (NASDAQ: PTX ) will cut 60 workers , mostly from its neurology sales staff, the company said today. As of the end of 2015, Pernix reported a headcount of 274. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. Last year, Pernix reported a $148.3
Xconomy
MAY 10, 2019
An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.
Xconomy
OCTOBER 5, 2018
subsidiary, Firmenich—which reported about $3.3 billion in sales in 2017—said Thursday it had had agreed to buy Senomyx for $1.50 But since then its stock price has fallen significantly, dropping below $1 per share multiple times in the past two years, which nearly got the listing booted from the Nasdaq exchange.
Xconomy
OCTOBER 9, 2017
billion this year through sales of digital tokens—so-called initial coin offerings or ICOs—and this method of fundraising exceeded traditional early-stage tech startup investments in June and July, CNBC reported in August. Companies have raised more than $1.25 Lubin is a former. Read more » Reprints | Share:
Expert insights. Personalized for you.
274 
Let's personalize your content